Collplant Biotechnologies Ltd (CLGN) — Capital Reinvestment Ratio
Collplant Biotechnologies Ltd (CLGN) has a Capital Reinvestment Ratio of 0.04x as of September 2023, meaning it reinvests 0% of its operating cash flow ($6.78 Million) in capital expenditures ($243.00K). See how leveraged is Collplant Biotechnologies Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Collplant Biotechnologies Ltd Capital Reinvestment Ratio (2021–2021)
This chart tracks Collplant Biotechnologies Ltd's Capital Reinvestment Ratio across 1 annual periods. Check total reinvestment intensity of Collplant Biotechnologies Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Collplant Biotechnologies Ltd (2021–2021)
Year-by-year Capital Reinvestment Ratio for Collplant Biotechnologies Ltd from 2021 to 2021. For live market cap and broader valuation context, see market cap of Collplant Biotechnologies Ltd.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.57x | $2.50 Million | $1.43 Million | — |